Originally characterized by the Sikiric group at the University of Zagreb School of Medicine, BPC-157 is unusual among peptides for its reported oral activity attributed to its origin in gastric juice, which suggests evolutionary adaptation to the digestive environment
This laboratory data is exactly what fuels the online marketing machine labeling it as the ultimate "gut-lining healer." In experimental rodent models of colitis, BPC 157 has shown real success in reducing tissue inflammation
Mild headaches: Some users report headaches during the first week of use
People who are B12 deficient either dont get enough of the nutrient in their diet, or they have a difficult time absorbing the nutrient
Nothing on PeptideStack is medical advice, treatment guidance, dosing instruction, or a recommendation for human consumption
Do I need previous experience